✦ LIBER ✦

A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis

✍ Scribed by Tong, W; Kantarjian, H; Thomas, D; Ravandi, F; Kornblau, S; Manshouri, T; Cortes, J E; Garcia-Manero, G; Verstovsek, S; Quintás-Cardama, A

Book ID: 109886835
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 132 KB
Volume: 22
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2008.91

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of tipifarnib in myelof

A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia

✍ Mesa, R A; Camoriano, J K; Geyer, S M; Wu, W; Kaufmann, S H; Rivera, C E; Erlich 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Primary myelofibrosis (PMF), post polycy

Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT)

✍ Ruben A. Mesa; Srdan Verstovsek; Francisco Cervantes; Giovanni Barosi; John T. R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 113 KB

The International Working Group for Myelofibrosis Research and Treatment (IWG-MRT) is comprised of hematologists, hematopathologists, and laboratory scientists and its main goal is to provide a forum for scientific exchange and collaboration. During its first general meeting in April 2006, the IWG-M

IDH1 and IDH2 mutation studies in 1473 p

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

✍ Tefferi, A; Lasho, T L; Abdel-Wahab, O; Guglielmelli, P; Patel, J; Caramazza, D; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 460 KB

Proposed criteria for the diagnosis of p

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment

✍ Barosi, G; Mesa, R A; Thiele, J; Cervantes, F; Campbell, P J; Verstovsek, S; Dup 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 81 KB

A higher JAK2 V617F-mutated clone is obs

A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis

✍ Bellosillo, B; Martínez-Avilés, L; Gimeno, E; Florensa, L; Longarón, R; Navarro, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB

A phase II study of 5-day intravenous az

A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes

✍ Mike G. Martin; Richard A. Walgren; Elizabeth Procknow; Geoffrey L. Uy; Keith St 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views